KING LUTHER CAPITAL MANAGEMENT CORP

Holdings History for scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

Symbol: SCPH
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 2,128,391 shares
Security Ownership %: 4%

Shares, Excluding Options vs Price

Value, Excluding Options

Luther King Capital Management Corporation ownership in scPharmaceuticals Inc. Common Stock, par value $0.0001 per share (SCPH)

08 Oct 2025 - Luther King Capital Management Corporation has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,128,391 shares of scPharmaceuticals Inc. Common Stock, par value $0.0001 per share (SCPH). This represents 4% ownership of the company. In their previous filing dated 21 Jul 2025, KING LUTHER CAPITAL MANAGEMENT CORP had reported owning 3,669,170 shares, indicating a decrease of +42%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Luther King Capital Management Corporation	4%	-43%	$11,982,841	2,128,391	-1,540,779	-42%	$5.63	13G/A	30 Sep 2025	08 Oct 2025, 17:02
J. Luther King, Jr.	7%	+7.1%	$13,979,905	3,669,170	+420,000	+13%	$3.81	13G/A	30 Jun 2025	21 Jul 2025, 16:01
J. Luther King, Jr.	6.5%	+8.3%	$8,122,925	3,249,170	+268,760	+9%	$2.50	13G/A	31 Mar 2025	28 Apr 2025, 16:01
J. Luther King, Jr.	6%		$7,451,025	2,980,410			$2.50	13G/A	31 Dec 2024	28 Jan 2025, 10:56

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0.05%	$0	0	-2,128,391	-100%	$5.67	Q4 2025
30 Sep 2025	0.05%	-0.03%	$12,067,977	2,128,391	-1,412,779	-40%	$5.67	Q3 2025
30 Jun 2025	0.06%	+0.01%	$13,491,858	3,541,170	+420,000	+13%	$3.81	Q2 2025
31 Mar 2025	0.04%	+0%	$8,208,677	3,121,170	+263,260		$2.63	Q1 2025
31 Dec 2024	0.04%	+0.01%	$10,117,001	2,857,910	+632,120	+28%	$3.54	Q4 2024
30 Sep 2024	0.04%	+0%	$10,149,602	2,225,790	+20,650	+0.94%	$4.56	Q3 2024
30 Jun 2024	0.04%	+0.01%	$9,592,359	2,205,140	+752,005	+52%	$4.35	Q2 2024
31 Mar 2024	0.03%	+0%	$7,294,738	1,453,135	+59,610	+4.3%	$5.02	Q1 2024
31 Dec 2023	0.04%	+0.01%	$8,737,402	1,393,525	+457,150	+49%	$6.27	Q4 2023
30 Sep 2023	0.03%	+0.01%	$6,666,990	936,375	+377,450	+68%	$7.12	Q3 2023
30 Jun 2023	0.03%	+0.01%	$5,695,446	558,925	+144,425	+35%	$10.19	Q2 2023
31 Mar 2023	0.02%	+0.02%	$3,759,515	414,500	+414,500	NEW	$9.07	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.